Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To determine when a drug loses patent protection in the United States
— Medical consultant, USA
To identify branded drug patent expiration and generic market entry
— CRO project manager, Portugal
For information on drug expiration / generic availability
— Pharmacist, USA
drugs and pharmaceutical products patents expiration details
— Marketing consultant, USA
To plan ahead for inventory purposes
— Pharmacy purchaser, USA
Generated: May 24, 2017
These international patent data are derived from patent families, based on US drug-patent linkages.
Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8,221,786 | Mar 21, 2028 | Astrazeneca Ab | QTERN | dapagliflozin propanediol; saxagliptin hydrochloride | |||||||||||||||||||||||||
| 8,221,786 | Mar 21, 2028 | Astrazeneca Ab | FARXIGA | dapagliflozin propanediol | |||||||||||||||||||||||||
| 8,716,251 | Mar 21, 2028 | Astrazeneca Ab | QTERN | dapagliflozin propanediol; saxagliptin hydrochloride | |||||||||||||||||||||||||
| 8,716,251 | Mar 21, 2028 | Astrazeneca Ab | FARXIGA | dapagliflozin propanediol | |||||||||||||||||||||||||
| 8,361,972 | Mar 21, 2028 | Astrazeneca Ab | QTERN | dapagliflozin propanediol; saxagliptin hydrochloride | |||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To update my knowledge in several markets
— Marketing professional, Spain
To prepare patent landscapes and give IP clearance for APIs
— Analyst, India
To gather valuable information on past, current, and future/prospective diabetes products
— Pharmacist, Luxembourg
To find all manufacturers of a drug with active DMFs
— CEO, specialty pharmaceutical firm, USA
To locate providers of active pharmaceutical ingredients and obtain any patent information that may apply
— Organic chemist at a generic drug manufacturer, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
